Back to Search Start Over

PapRIV, a BV-2 microglial cell activating quorum sensing peptide

Authors :
Christel Claes
Peter Paul De Deyn
Peter Ponsaerts
Evelien Wynendaele
Lidia Feliu
Nathan Debunne
Matthew Blurton-Jones
Bart De Spiegeleer
Debby Van Dam
Marta Planas
Alessandra Quarta
Yorick Janssens
Anton De Spiegeleer
Molecular Neuroscience and Ageing Research (MOLAR)
Source :
Scientific reports, vol 11, iss 1, Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021), Scientific reports, Scientific Reports, 11(1):10723. Nature Publishing Group, SCIENTIFIC REPORTS, Scientific Reports, Scientific Reports, 2021, vol. 11, art.núm.10723, Articles publicats (D-Q), Janssens, YYorick Debunne, NNathan De Spiegeleer, Anton Wynendaele, Evelien Planas i Grabuleda, Marta Feliu Soley, Lídia Quarta, Alessandra Claes, Christel Van Dam, Debby Paul De Deyn, Peter Paul Ponsaerts, Peter Blurton-Jones, Matthew De Spiegeleer, Bart 2021 PapRIV, a BV-2 microglial cell activating quorum sensing peptide Scientific Reports 11 art.núm.10723, DUGiDocs – Universitat de Girona, instname
Publication Year :
2021
Publisher :
eScholarship, University of California, 2021.

Abstract

BackgroundQuorum sensing peptides (QSPs) are bacterial peptides produced by Gram-positive bacteria to communicate with their peers in a cell-density dependent manner. These peptides do not only act as interbacterial communication signals, but can also have effects on the host. Compelling evidence demonstrates the presence of a gut-brain axis and more specifically, the role of the gut microbiota in microglial functioning. The aim of this study is to investigate microglial activating properties of a selected QSP (PapRIV) which is produced byBacillus cereusspecies.MethodsGastro-intestinal transport of the peptide is investigated using thein vitroCaco-2 model while transport over the blood-brain barrier is investigated in mice using multiple time regression experiments. Microglial activation is assessed using ELISA, fluorometry, immunoblotting, qPCR and phase-contrast microscopy.In vivoplasma detection andex vivometabolization experiments are performed using UHPLC-MS2and UHPLC-UV/MS, respectively.ResultsPapRIV showedin vitroactivating properties of BV-2 microglia cells and was able to cross thein vitroCaco-2 cell model and pass the blood-brain barrierin vivo.In vivopeptide presence was also demonstrated in mouse plasma. The peptide caused induction of IL-6, TNFα and ROS expression and increased the fraction of ameboid BV-2 microglia cells in an NF-κB dependent manner. Different metabolites were identified in serum, of which the main metabolite (DLPFEH) still remained active.ConclusionsPapRIV is thus able to cross the gastro-intestinal tract and the blood-brain barrier and showsin vitroactivating properties in BV-2 microglia cells, hereby indicating a potential role of this quorum sensing peptide in gut-brain interaction.

Details

ISSN :
20452322
Database :
OpenAIRE
Journal :
Scientific reports, vol 11, iss 1, Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021), Scientific reports, Scientific Reports, 11(1):10723. Nature Publishing Group, SCIENTIFIC REPORTS, Scientific Reports, Scientific Reports, 2021, vol. 11, art.núm.10723, Articles publicats (D-Q), Janssens, YYorick Debunne, NNathan De Spiegeleer, Anton Wynendaele, Evelien Planas i Grabuleda, Marta Feliu Soley, Lídia Quarta, Alessandra Claes, Christel Van Dam, Debby Paul De Deyn, Peter Paul Ponsaerts, Peter Blurton-Jones, Matthew De Spiegeleer, Bart 2021 PapRIV, a BV-2 microglial cell activating quorum sensing peptide Scientific Reports 11 art.núm.10723, DUGiDocs – Universitat de Girona, instname
Accession number :
edsair.doi.dedup.....6da96108e1287b302a736f10c453ffa4